The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
1110764417 11107644 17 F 20150415 20160803 20150512 20160811 EXP CA-PFIZER INC-2015138590 PFIZER 52.00 YR F Y 0.00000 20160811 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
1110764417 11107644 1 PS XELJANZ TOFACITINIB CITRATE 1 Oral 5 MG, 2X/DAY Y 203214 5 MG TABLET BID
1110764417 11107644 2 SS XELJANZ TOFACITINIB CITRATE 1 Oral 5 MG, 2X/DAY Y 203214 5 MG TABLET BID
1110764417 11107644 3 SS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 25 MG, UNK 11719 25 MG
1110764417 11107644 4 SS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 1 MG, WEEKLY 11719 1 MG /wk
1110764417 11107644 5 SS CELEBREX CELECOXIB 1 TWICE A DAY 20998 CAPSULE, HARD BID
1110764417 11107644 6 SS SULFASALAZINE. SULFASALAZINE 1 Rectal 1 G, 2X/DAY Y 7073 1 G RECTAL GEL BID
1110764417 11107644 7 SS ARAVA LEFLUNOMIDE 1 UNK Y 0
1110764417 11107644 8 SS LEFLUNOMIDE. LEFLUNOMIDE 1 Oral 20 G, UNK U 0 20 G
1110764417 11107644 9 SS PLAQUENIL HYDROXYCHLOROQUINE SULFATE 1 Oral UNK Y 0
1110764417 11107644 10 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) 30 MG, UNK Y 0 30 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
1110764417 11107644 1 Rheumatoid arthritis
1110764417 11107644 3 Rheumatoid arthritis
1110764417 11107644 5 Rheumatoid arthritis
1110764417 11107644 6 Rheumatoid arthritis
1110764417 11107644 7 Rheumatoid arthritis
1110764417 11107644 8 Rheumatoid arthritis
1110764417 11107644 9 Rheumatoid arthritis
1110764417 11107644 10 Rheumatoid arthritis

Outcome of event

Event ID CASEID OUTC COD
1110764417 11107644 OT
1110764417 11107644 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
1110764417 11107644 Arthralgia
1110764417 11107644 Carpal tunnel syndrome
1110764417 11107644 Condition aggravated
1110764417 11107644 Drug dose omission
1110764417 11107644 Drug ineffective
1110764417 11107644 Fatigue
1110764417 11107644 Headache
1110764417 11107644 Inflammation
1110764417 11107644 Insomnia
1110764417 11107644 Joint swelling
1110764417 11107644 Migraine
1110764417 11107644 Musculoskeletal stiffness
1110764417 11107644 Nasal congestion
1110764417 11107644 Nasopharyngitis
1110764417 11107644 Paraesthesia
1110764417 11107644 Rheumatoid arthritis
1110764417 11107644 Rhinorrhoea

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
1110764417 11107644 1 20150903 20160211 0
1110764417 11107644 2 20160322 0
1110764417 11107644 3 2009 0
1110764417 11107644 5 2005 0
1110764417 11107644 6 2006 2010 0
1110764417 11107644 8 2010 0
1110764417 11107644 9 2006 2010 0
1110764417 11107644 10 2011 2012 0